Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Tiotropium on Walking Capacity in COPD
NCT01307189Phase 4Completed
- Sponsor
- Université Laval
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Université Laval. Started Apr 2005; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01307189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01307189.